Animal Antibiotics and Antimicrobials Market Size, Share, Growth, Trends, and Global Industry Analysis: By Product Type (Tetracyclines, Penicillins, Sulfonamides, Macrolides, Aminoglycosides, Lincosamides, Fluoroquinolones, Cephalosporins and Other Antimicrobials and Antibiotics), By Mode of Delivery (Premixes, Oral Powder, Oral Solution, Injection and Others) By Animal Type (Food-Producing Animals, Companion Animals), and Region Forecast 2019-2030  

Animal Antibiotics and Antimicrobials Market size was valued at US$ 5.1 billion in 2024 and is expected to reach US$ 6.7 billion by 2031, growing at a significant CAGR of 4.1% from 2025-2031. The global market provides a detailed overview of the market, which can be segmented by product type, mode of delivery, and animal type. By product type, the market has been segmented into tetracyclines, penicillin, sulfonamides, macrolides, aminoglycosides, lincosamides, fluoroquinolones, cephalosporins, and other antimicrobials and antibiotics. The penicillins segment is likely to be the largest and fastest-growing segment in terms of product type.

Based on the mode of delivery, the animal antibiotics and antimicrobials market is segmented into premixes, oral powder, oral solution, injection, and others. Among these, the premixes segment is expected to have the fastest-growing market during the forecast period. Based on animal type, the market is segregated into food-producing animals and companion animals. The food-producing animal segment held a considerable market share during the forecast period.  

Key Developments

• In Jul 2020, Zoetis collaborated with Trianni, Inc to build transgenic monoclonal antibody platforms to develop novel veterinary therapeutics.